In a consultation the UK’s drugs watchdog has now proposed the NHS expands its use for weight loss for those who are severely obese under a phased rollout. In a consultation the UK’s drugs watchdog has now proposed the NHS expands its use for weight loss for those who are severely obese under a phased rollout.
Hoping to get Mounjaro on the NHS? Millions may miss out on King Kong weight loss jab because of health chiefs’ BIG mistake, say experts
